Sustained unresponsiveness to peanut after long-term peanut epicutaneous immunotherapy
J Allergy Clin Immunol Pract
.
2021 Jan;9(1):524-526.
doi: 10.1016/j.jaip.2020.08.017.
Epub 2020 Aug 22.
Authors
Terri F Brown-Whitehorn
1
,
Frédéric de Blay
2
,
Jonathan M Spergel
3
,
Todd D Green
4
,
Aurélie Peillon
5
,
Hugh A Sampson
6
,
Dianne E Campbell
7
Affiliations
1
Children's Hospital of Philadelphia, Philadelphia, Pa. Electronic address: brownte@email.chop.edu.
2
Strasbourg University Hospital, Federation of Translational Medicine, University of Strasbourg, Strasbourg, France.
3
Children's Hospital of Philadelphia, Philadelphia, Pa.
4
DBV Technologies, Montrouge, France; UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pa.
5
DBV Technologies, Montrouge, France.
6
DBV Technologies, Montrouge, France; Icahn School of Medicine at Mount Sinai, New York, NY.
7
DBV Technologies, Montrouge, France; Children's Hospital at Westmead, Sydney, NSW, Australia.
PMID:
32835872
DOI:
10.1016/j.jaip.2020.08.017
No abstract available
MeSH terms
Administration, Oral
Allergens / therapeutic use
Arachis*
Desensitization, Immunologic
Humans
Immunotherapy
Peanut Hypersensitivity* / drug therapy
Substances
Allergens